Search

Author/Creator Block, Matthew S.

1. A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients with Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1. (1st January 2020)

Authors:
Somaiah, Neeta; Chawla, Sant P.; Block, Matthew S.; Morris, John C.; Do, Khanh; Kim, Joseph W.; Druta, Mihaela; Sankhala, Kamalesh K.; Hwu, Patrick; Jones, Robin L.; Gnjatic, Sacha; Kim-Schulze, Seunghee; Tuballes, Kevin; Yishak, Mahlet; Lu, Hailing; Yakovich, Adam; Ter Meulen, Jan; Chen, Michael...
Journal:
Oncoimmunology
Issue:
Volume 9:Number 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma. Issue 4 (August 2017)

Authors:
Leon-Ferre, Roberto A.; Kottschade, Lisa A.; Block, Matthew S.; McWilliams, Robert R.; Dronca, Roxana S.; Creagan, Edward T.; Allred, Jacob B.; Lowe, Val J.; Markovic, Svetomir N.
Journal:
Melanoma research
Issue:
Volume 27:Issue 4(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients. Issue 4 (August 2020)

Authors:
Vera Aguilera, Jesus; Paludo, Jonas; McWilliams, Robert R.; Zhang, Henan; Li, Ying; Kumar, Anagha B.; Failing, Jarrett; Kottschade, Lisa A.; Block, Matthew S.; Markovic, Svetomir N.; Dong, Haidong; Dronca, Roxana S.; Yan, Yiyi
Journal:
Melanoma research
Issue:
Volume 30:Issue 4(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer. (1st January 2020)

Authors:
Ren, Yingxue; Cherukuri, Yesesri; Wickland, Daniel P.; Sarangi, Vivekananda; Tian, Shulan; Carter, Jodi M.; Mansfield, Aaron S.; Block, Matthew S.; Sherman, Mark E.; Knutson, Keith L.; Lin, Yi; Asmann, Yan W.
Journal:
Oncoimmunology
Issue:
Volume 9:Number 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Immune‐related hematologic adverse events in the context of immune checkpoint inhibitor therapy. Issue 10 (2nd July 2021)

Authors:
Saliba, Antoine N.; Xie, Zhuoer; Higgins, Alexandra S.; Andrade‐Gonzalez, Xavier A.; Fuentes‐Bayne, Harry E.; Hampel, Paul J.; Kankeu Fonkoua, Lionel A.; Childs, Daniel S.; Rakshit, Sagar; Bezerra, Evandro D.; Kommalapati, Anuhya; Lou, Yanyan; Rivera, Candido E.; Price, Katharine A.; Chintakuntla...
Journal:
American journal of hematology
Issue:
Volume 96:Issue 10(2021)
Page Start:
E362
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples. Issue 7 (May 2015)

Authors:
Winterhoff, Boris; Freyer, Luisa; Hammond, Edward; Giri, Shailendra; Mondal, Susmita; Roy, Debarshi; Teoman, Attila; Mullany, Sally A.; Hoffmann, Robert; von Bismarck, Antonia; Chien, Jeremy; Block, Matthew S.; Millward, Michael; Bampton, Darryn; Dredge, Keith; Shridhar, Viji
Journal:
European journal of cancer
Issue:
Volume 51:Issue 7(2015:May)
Page Start:
879
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗